Antibodies that target human CD47
US10858442B2 · kind B2 · utility
0Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 17, 2020 |
| Grant date | Dec 8, 2020 |
| Priority date | — |
| Expiry date | Apr 17, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Provided are isolated antibodies that bind to and block CD47, vectors comprising a nucleic acid molecule encoding an amino acid sequence of the binding molecule, and host cells containing the vectors. Methods of making the antibodies, pharmaceutical compositions containing the antibodies, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, such as in treating diseases including cancer, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.